NEW YORK, Feb 12, 2019 /PRNewswire/ --
A new report published by Research on Global Markets titled 'Global Multiplex Biomarker Imaging Market (2018-2023)' studies the performance of the global multiplex biomarker imaging market over a five-year assessment period, from 2018 till 2023. The report presents the value forecast of the global multiplex biomarker imaging market and provides key insights into the factors driving, as well as restricting market growth. According to the report, the global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018–2023 period, generating a revenue of USD 523.59 Mn by 2023.
The global multiplex biomarker imaging market is segmented based on component types, imaging techniques, applications, and end users.
Within the imaging technique segment, immunohistochemistry (IHC) held the largest market share (around 47%) in 2017 owing to its widespread use in research laboratories and clinical diagnostics.
Among the component types, instruments currently hold the largest market share. However, software is anticipated to witness the highest growth during the forecast period.
In terms of applications, multiplex biomarker imaging products are used widely in oncology studies, followed by drug safety applications, which is expected to expand at a CAGR of 14.1% during 2018–2023.
Research on Global Markets tracks the performance of the global multiplex biomarker imaging market across the key geographies of North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa. According to the report, North America dominated the global multiplex biomarker imaging market in with a share of 50% in 2017, followed by Europe with a 28% share. Asia-Pacific is expected to expand at the highest CAGR (16.0%) during 2018–2023.
The report covers some of the key players operating in the global multiplex biomarker imaging market, such as Perkin Elmer, Inc., Bio-rad Laboratories Inc., Thermo Fisher Scientific, Inc., Abcam plc., Merck KGaA, Illumina Inc., Leica Biosystems Nussloch GmbH, Ventana Medical Systems, Inc., Aushon BioSystems Ltd., MicroConstants, Inc., and ToposNomos Ltd.
Key highlights of the report:
Scope and segmentation of the global multiplex biomarker imaging market
A comprehensive overview of the historical, current and predicted market size, revenue, and market attractiveness analysis
Market segmentation and analysis based on imaging techniques – immunohistochemistry, fluorescent in-situ hybridization, immunofluorescence, toponome imaging system, and tissue microarray
Market segmentation and analysis based on components – kits, instruments, reagents, and software
Market segmentation and analysis based on application and usage – drug safety, oncology, protein research, and neurodegeneration
Regional market analysis of North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa
Overview of the competitive landscape and analysis of key players operating in the industry
About Research on Global Markets
Owned by Netscribes, Research on Global Markets is the go-to platform for global professionals looking for credible and transparent research on developed and emerging markets. We set ourselves apart from other online market research publishers with our focused coverage, commitment to data authenticity, simple licensing, and complete user privacy.
For further information, please contact:
+91-9810439898 / 18888313350
SOURCE Research on Global Markets